# Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

> **NCT03635437** · PHASE1,PHASE2 · COMPLETED · sponsor: **Per-Ola Carlsson** · enrollment: 35 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Gamma-Aminobutyric Acid (GABA)
- **DRUG:** Alprazolam

## Key facts

- **NCT ID:** NCT03635437
- **Lead sponsor:** Per-Ola Carlsson
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2022-09-27
- **Final completion:** 2022-09-27
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03635437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03635437, "Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03635437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*